Legal Representation
Attorney
Elizabeth Lee D'Amore
USPTO Deadlines
Next Deadline
2123 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-05-27)
Due Date
May 27, 2031
Grace Period Ends
November 27, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 27, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| May 27, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 8, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 8, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 2, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 13, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 12, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 12, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 12, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 22, 2025 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Jan 31, 2025 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Jan 31, 2025 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Dec 28, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Dec 27, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 22, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 30, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jul 30, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 26, 2024 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 040
Custom manufacture of medicines, namely, custom manufacture of pharmaceuticals; custom manufacture of biopharmaceuticals; custom manufacture of dietary supplements for humans; transformation of biopharmaceutical materials for third parties, namely, custom manufacture of biopharmaceuticals
Class 042
Research and development of pharmaceutical products in connection with biotechnology; research in the field of gene editing technology; scientific testing services in the field of pharmaceutical products; clinical studies for pharmaceutical products, namely, scientific studies in the field of pharmaceutical products; biotechnology testing, namely, scientific testing in the field of biotechnology; scientific and medical research information regarding pharmaceutical products and clinical trials; medical research laboratory services; biological research laboratory services; biological research, clinical research in the field of pharmaceutical, and medical research
Additional Information
Design Mark
The mark consists of the stylized wording "3PBIOVIAN" in a gradient shading consisting of pink on the left to blue on the right, on a white background.
Color Claim
The color(s) pink, blue, and white is/are claimed as a feature of the mark.
Pseudo Mark
3P BIOVIAN; THREE P BIOVIAN
Classification
International Classes
040
042